China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $3,732 | $8,124 | $8,385 | $8,819 |
| % Growth | -54.1% | -3.1% | -4.9% | – |
| Cost of Goods Sold | $1,914 | $4,329 | $4,324 | $4,302 |
| Gross Profit | $1,817 | $3,795 | $4,061 | $4,517 |
| % Margin | 48.7% | 46.7% | 48.4% | 51.2% |
| R&D Expenses | $128 | $328 | $268 | $372 |
| G&A Expenses | $250 | $273 | $256 | $289 |
| SG&A Expenses | $1,623 | $1,581 | $1,711 | $1,879 |
| Sales & Mktg Exp. | $1,278 | $1,333 | $1,376 | $1,608 |
| Other Operating Expenses | $84 | $1,935 | $1,698 | $1,652 |
| Operating Expenses | $1,835 | $3,844 | $3,677 | $3,903 |
| Operating Income | -$18 | -$49 | $385 | $613 |
| % Margin | -0.5% | -0.6% | 4.6% | 7% |
| Other Income/Exp. Net | -$24 | -$87 | -$85 | -$96 |
| Pre-Tax Income | -$41 | -$136 | $299 | $518 |
| Tax Expense | $29 | $57 | $85 | -$261 |
| Net Income | -$54 | -$157 | $211 | $706 |
| % Margin | -1.4% | -1.9% | 2.5% | 8% |
| EPS | -0.011 | -0.031 | 0.042 | 0.14 |
| % Growth | 65.7% | -174.5% | -70.1% | – |
| EPS Diluted | -0.011 | -0.031 | 0.042 | 0.14 |
| Weighted Avg Shares Out | 5,036 | 5,036 | 5,036 | 5,036 |
| Weighted Avg Shares Out Dil | 5,036 | 5,036 | 5,036 | 5,036 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $48 | $0 | -$9 |
| Interest Expense | $14 | $236 | $0 | -$39 |
| Depreciation & Amortization | $266 | $594 | $537 | $528 |
| EBITDA | $360 | $621 | $908 | $1,094 |
| % Margin | 9.7% | 7.6% | 10.8% | 12.4% |